Research graph
References from Analysis of the clinical profile of multiple endocrine neoplasia syndromes and the association with other tumors. Local targets link to admitted publications; unresolved targets remain external evidence.
Multiple Endocrine Neoplasia Syndromes
10.1097/nan.0000000000000143 · 2015 · External reference
Multiple Endocrine Neoplasia Syndromes: A Comprehensive Imaging Review
10.1016/j.rcl.2015.12.001 · 2016 · External reference
Multiple endocrine neoplasia: an update
10.1111/imj.14394 · 2019 · External reference
Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review
10.1210/clinem/dgae055 · 2024 · External reference
Clinical aspects of multiple endocrine neoplasia type 1
10.1038/s41574-021-00468-3 · 2021 · External reference
Breast-cancer predisposition in multiple endocrine neoplasia type 1
10.1056/nejmc1406028 · 2014 · External reference
Menin links estrogen receptor activation to histone H3K4 trimethylation
10.1158/0008-5472.can-05-4461 · 2006 · External reference
Roles of the RETProto-oncogene in Cancer and Development
10.31662/jmaj.2020-0021 · 2020 · External reference
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas
10.1016/0092-8674(90)90659-3 · 1990 · External reference
RET/PTC rearrangement in thyroid tumors
10.1385/ep:13:1:03 · 2002 · External reference
RET, ROS1 and ALK fusions in lung cancer
10.1038/nm.2658 · 2012 · External reference
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)
10.1210/jc.2012-1230 · 2012 · External reference
Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database
10.1007/s12020-017-1234-4 · 2017 · External reference
Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database
10.1111/j.1365-2265.2011.04227.x · 2012 · External reference
Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers
10.1111/j.1365-2265.2007.02934.x · 2007 · External reference
Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients
10.1186/s13023-018-0938-8 · 2018 · External reference
Better Survival But Changing Causes of Death in Patients With Multiple Endocrine Neoplasia Type 1
10.1097/sla.0000000000001211 · 2015 · External reference
Adrenal Liposarcoma: A Novel Presentation of Multiple Endocrine Neoplasia Type 1
2022 · External reference
Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome
10.3389/fendo.2023.1191040 · 2023 · External reference
A Novel Missense MEN1 Mutation in a Sporadic Case of Multiple Endocrine Neoplasia Type 1 Complicated with Papillary Thyroid Carcinoma
10.31662/jmaj.2022-0187 · 2023 · External reference
Multiple endocrine neoplasia type 1 combined with thyroid neoplasm: A case report and review of literatures
10.12998/wjcc.v10.i3.1032 · 2022 · External reference
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior
10.1097/pas.0b013e3181e2b726 · 2010 · External reference
Myxoid adrenal cortical neoplasms
10.1016/j.anndiagpath.2008.04.002 · 2008 · External reference
MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients
10.1186/s12916-016-0708-1 · 2016 · External reference
The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation
10.1128/mcb.01001-08 · 2009 · External reference
Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)
10.1038/s41379-020-0574-4 · 2020 · External reference
Evaluating the role of MEN1 gene expression and its clinical significance in breast cancer patients
10.1371/journal.pone.0288482 · 2023 · External reference
Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer
10.1016/j.celrep.2017.02.025 · 2017 · External reference
Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancer
2025 · External reference
Hypernephroma associated with multiple endocrine neoplasia type I: a case report
10.1016/s0022-5347(17)45120-2 · 1986 · External reference
Syndrome de Wermer associé à une tumeur rénale bilatérale [Wermer syndrome associated with a bilateral renal tumor]
1996 · External reference
Sarcomatoid carcinoma of the kidney in a MEN1 patient: case report and genetic profile
10.1507/endocrj.ej14-0021 · 2014 · External reference
A Possible New Multiple Endocrine Neoplasia Mutation in a Patient with a Prototypic Multiple Endocrine Neoplasia Presentation
10.1159/000440985 · 2016 · External reference
Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex
2003 · External reference
Menin: a scaffold protein that controls gene expression and cell signaling
10.1016/j.tibs.2013.05.005 · 2013 · External reference
Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity
10.1038/s41388-021-02039-2 · 2022 · External reference
Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations
10.3389/fendo.2020.591501 · 2020 · External reference
UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French Population
10.1210/jc.2018-01170 · 2019 · External reference
Multiple endocrine neoplasia type 2: an overview
10.1097/gim.0b013e318216cc6d · 2011 · External reference
American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma
10.1089/thy.2014.0335 · 2015 · External reference
A narrative review of multiple endocrine neoplasia syndromes: genetics, clinical features, imaging findings, and diagnosis
10.21037/atm-21-1165 · 2021 · External reference
Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management
10.14310/horm.2002.1218 · 2009 · External reference
Distribution of RET Mutations in Multiple Endocrine Neoplasia 2 in Denmark 1994-2014: A Nationwide Study
10.1089/thy.2016.0411 · 2017 · External reference
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes
10.1530/eje-10-0333 · 2010 · External reference
RET rearrangements are actionable alterations in breast cancer
10.1038/s41467-018-07341-4 · 2018 · External reference
Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC
10.1016/j.jtho.2018.06.021 · 2018 · External reference
RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients
10.1158/1078-0432.ccr-16-1679 · 2017 · External reference
RET fusions in solid tumors
10.1016/j.ctrv.2019.101911 · 2019 · External reference
A comprehensive overview of the relationship between RET gene and tumor occurrence
2023 · External reference
